Farshid Gelareh, Rush Gill
BreastScreen SA, Division of Tissue Pathology, Institute of Medical and Veterinary Science, Adelaide, South Australia.
Am J Surg Pathol. 2004 Dec;28(12):1626-31. doi: 10.1097/00000478-200412000-00012.
Because some lesions diagnosed as radial scars (RS) on core biopsy have been found to be malignant on excision, core biopsy has not had an established role in the assessment of RS. In our breast cancer-screening program, we have avoided core biopsy if RS is suspected on imaging. Recently, two reports have expanded the experience with core biopsy of RS, prompting this review of our assessment protocols for lesions suspected as being RS. Between January 1996 and January 2003, stellate lesions with imaging features of RS in which core biopsy was omitted because of a presumptive radiologic diagnosis of RS are included. Demographic, radiologic, and cytologic data were correlated with the histologic findings in the excised specimen. On imaging, 9% (142) of all stellate lesions were suspected to be RS. Only 66.2% (94) were confirmed as RS on histology; 38 cases (28.6%) were carcinomas (36 invasive, 2 in situ) and 7% showed benign fibrocystic changes; 87.1% of the carcinomas required further surgery for positive margins. Axillary staging was also needed for the invasive cancers. Among the histologically proven RS, 28 of 94 (29.8%) showed areas of atypical ductal hyperplasia, lobular neoplasia, ductal carcinoma in situ, or invasive carcinoma. These proliferations were typically focal and unpredictable and were usually completely excised by the initial diagnostic biopsy. Core biopsy would be valuable in the assessment of lesions with imaging features suggestive of RS since 28.6% of such lesions are indeed carcinomas that mimic RS. Identification of these cancers would permit one stage breast and axillary surgery to be planned. The policy of mammographic surveillance for lesions with nonmalignant core biopsies remains controversial because of the paucity of data. Ongoing evaluation is needed as more experience is reported.
由于一些在粗针活检中被诊断为放射状瘢痕(RS)的病变在切除后被发现为恶性,因此粗针活检在RS的评估中尚未确立明确作用。在我们的乳腺癌筛查项目中,如果影像学检查怀疑为RS,我们会避免进行粗针活检。最近,有两份报告扩展了RS粗针活检的经验,促使我们对疑似RS病变的评估方案进行此次回顾。纳入了1996年1月至2003年1月期间具有RS影像学特征的星芒状病变,这些病变因放射学初步诊断为RS而未进行粗针活检。将人口统计学、放射学和细胞学数据与切除标本的组织学结果进行关联。在影像学上,所有星芒状病变中有9%(142例)被怀疑为RS。组织学上仅66.2%(94例)被确认为RS;38例(28.6%)为癌(36例浸润性癌,2例原位癌),7%表现为良性纤维囊性改变;87.1%的癌因切缘阳性需要进一步手术。浸润性癌还需要进行腋窝分期。在组织学证实为RS的病例中,94例中有28例(29.8%)显示非典型导管增生、小叶肿瘤、导管原位癌或浸润性癌区域。这些增生通常为局灶性且不可预测,通常通过初始诊断性活检可完全切除。粗针活检对于评估具有提示RS影像学特征的病变具有重要价值,因为此类病变中有28.6%实际上是模仿RS的癌。识别这些癌症将有助于规划一期乳房和腋窝手术。由于数据匮乏,对粗针活检为非恶性病变进行乳腺X线监测的策略仍存在争议。随着更多经验的报道,需要持续进行评估。